Epilepsy drug lingers despite birth defect risk birth defectCenter for Spina Bifida ResearchGodfrey P. Oakley Jr.prescriptionsPrevention
A recent study shows that prescriptions for the drug valproate have not decreased in recent years, despite awareness of the birth defect and brain damage risk.
“We were surprised to find that there was no decrease in the number of valproate prescriptions prescribed to women of reproductive-age despite the numerous, less harmful antiepileptic drugs available and the proven evidence of valproate’s harmful effects during pregnancy,” says Godfrey P. Oakley Jr., research professor at Emory University’s Rollins School of Public Health and the director of Emory’s Center for Spina Bifida Research, Prevention, and Policy.
Full story at Futurity.
More research news from top universities.
Photo credit: Melanie Tata/FlickrPosted by Futurity